Preferential Vβ3 usage by hepatic T lymphocytes in patients with primary sclerosing cholangitis

Journal of Hepatology

Volumn 26, Issue 3, 1997, Pages 527-534

  Brommé, Ulrika ^a   Grunewald, Johan ^b   Scheynius, Annika ^b   Olerup, Olle ^b   Hultcrantz, Rolf ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

liver biopsy specimens; primary biliary cirrhosis; primary sclerosing cholangitis; T cell receptors

Indexed keywords

HLA ANTIGEN CLASS 2; LYMPHOCYTE RECEPTOR; MONOCLONAL ANTIBODY; LYMPHOCYTE ANTIGEN RECEPTOR;

ADULT; ARTICLE; BILIARY CIRRHOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; SCLEROSING CHOLANGITIS; T LYMPHOCYTE; AGED; COMPARATIVE STUDY; GENETICS; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; LIVER; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; CHOLANGITIS, SCLEROSING; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES;

EID: 0030615212     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80417-5     Document Type: Article

References (47)

1. RH Wiesner, LaRusso NF, Ludwig J, Dickson ER. Comparison of the clinicopathological features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology. 88:1985;108-114.
2. Chapman RWG, Arborgh BAM, Rhodes JM, Summerfield JA, Dick R, Schueuer PJ, Sherlock S. Primary sclerosing cholangitis: a review of its clinical features, cholangiography and hepatic histology. Gut. 21:1980;870-877.
3. Sherlock S, Scheuer PJ. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med. 287:1973;674-678.
4. MacSween RNM, Anthony PP, Scheuer PJ. Pathology of the Liver. 1987;436-441 Churchill Livingstone, London.
5. Whiteside TL, Lansky S, Si L, van Thiel DH. Immunologic analysis of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis. Hepatology. 5:1985;468-474.
6. Yamada G, Hyodo I, Tobe K, Mizuno M, Nishihara T, Kobayashi T, Nagashima H. Ultrastructural immunohistochemical analysis of lymphocytes infiltrating bile duct epithelia in primary biliary cirrhosis. Hepatology. 6:1986;385-391.
7. Sanchez-Tapias J, Thomas H, Sherlock S. Lymphocyte populations in liver biopsy specimens from patients with primary biliary cirrhosis. Gut. 18:1977;472-475.
8. Lindor KD, Wiesner RH, Katzman JA, LaRusso NF, Beaver SJ. Lymphocyte subsets in primary sclerosing cholangitis. Dig Dis Sci. 32:1987;720-725.
9. Björkland A, Festin R, Mendel-Hartvig I, Nyberg A, Lööf L, Tötterman Th. Blood and liver-infiltrating lymphocytes in primary biliary cirrhosis: increase in actived T and natural killer cells and recruitment of primed memory T cells. Hepatology. 13:1991;1106-1111.
10. Lindor KD, Wiesner RH, La Russo NF, Homburger HA. Enhanced autoreactivity of T-lymphocytes in primary sclerosing cholangitis. Hepatology. 7:1987;884-888.
11. Spengler U, Pape GR, Hoffmann RM. Differential expression on MHC class subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosis. Hepatology. 8:1988;459-462.
12. Broomé U, Glaumann H, Hultcrantz R, Forsum U. Distribution of HLA-DR, HLA-DP, HLA-DQ antigens in liver tissue from patients with primary sclerosing cholangitis. Scand J Gastroenterol. 25:1990;54-58.
13. Broomé U, Hultcrantz R, Scheynius A. Lack of concomitant expression of ICAM-1 and HLA-DR on bile duct cells from patients with primary sclerosing cholangitis and primary biliary cirrhosis. Scand J Gastroenterol. 28:1993;126-130.
14. Braciale V. Antigen presentation: structural themes and functional variations. Immunol Today. 12:1991;124-129.
15. Reed E, Tugulea SL, Suciu-Foca N. Influence of HLA Class I and II antigens on the peripheral T-cell receptor repertoire. Hum Immunol. 40:1994;111-122.
16. Prochazka EJ, Terasaki PI, Park MS, Goldstein LI, Busuttil RW. Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med. 322:1990;1842-1844.
17. Zetterquist H, Broomé U, Einarsson K, Olerup O. HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis. Gut. 33:1992;942-946.
18. Donaldson PT, Farrant JM, Wilkinson ML, Hayllar K, Portmann BC, Williams R. Dual associations of HLA DR2 and DR3 with primary sclerosing cholangitis. Hepatology. 13:1991;129-133.
19. Mehal WZ, Lo YMD, Wordsworth BP, Neuberger JM, Hubscher SC, Fleming KA, Chapman RW. HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis. Gastroenterology. 106:1994;160-167.
20. Olerup O, Olsson R, Hultcrantz R, Broomé U. HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis. Gastroenterology. 108:1995;870-878.
21. Davies DR, Metzger H. Structural basis of antibody function. Ann Rev Immunol. 1:1983;87-117.
22. Oksenberg JR, Stuart S, Begovich AB, Bell RB, Erlich HA, Steinman L, Bernhard CC. Limited heterogeneity of rearranged T cell receptor Vα transcripts in brains of multiple sclerosis patients. Nature. 345:1990;344-346.
23. Sottini K, Imbert L, Golla R, Cattaneo R, Primi D. Restricted expression of T cell receptor Vβ but not Vα genes in rheumatoid arthritis. Eur J Immunol. 21:1991;451-466.
24. Sumida T, Kita Y, Yonaha F, Maeda T, Iwamot I, Yoshida S. T cell receptor Vα repertoire of infiltrating T cells in labial salivary glands from patients with Sjögren's syndrome. J Rheumatol. 21:1994;1655-1661.
25. Grunewald J, Olerup O, Persson U, Öhrn M, Wigzell H, Eklund A. T cell receptor variable region usage by CD4+ and CD8+ T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Proc Natl Acad Sci USA. 91:1994;4965-4969.
26. Chang JC, Smith LR, Froning KJ, Scwabe BJ, Laxer JA, Caralli LL, Kurland HH, Karasek MA, Wilkinsson DI, Carlo DJ, Brostoff SW. CD8+ T cells in psoriatic lesions preferentially use T cell receptor Vβ3 and/or Vβ13.1 genes. Proc Natl Acad Sci USa. 91:1994;9282-9286.
27. Moebius U, Manns M, Hess G, Kober G, Meyer zum Büschenfelde, Meuer SC. T cell receptor gene rearrangements of T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis (PBC): oligoclonality of PBC-derived T cell clones. Eur J Immunol. 20:1990;889-896.
28. Diu A, Moebius U, Ferradini L, Genevee C, Roman-roman S, Claudon M, Delorme D, Meuer S, Hercend T, Praz F. Limited T-cell receptor diversity in liver infiltrating lymphocytes from patients with primary biliary cirrhosis. J Autoimmun. 5:1993;611-619.
29. DerSimonian H, Band H, Brenner M. Increased frequency of T cell receptor Vα 12.1 expression on T cells: evidence that Vα participate is shaping the peripheral T cell repertoire. J Exp Med. 174:1991;639-648.
30. Carlsson B, Wallin J, Böhme J, Möller E. HLA-DR-DQ haplotypes defined by restriction fragment length analysis - correlation to serology. Hum Immunol. 20:1987;95-113.
31. Herrman A, Kappler JW, Marrack P, Pullen AM. Superantigenes: mechanism of T cell stimulation and role in immune responses. Annu Rev Immunol. 9:1991;745-775.
32. Choi Y, Lafferty JA, Clements K, Tudd JK, Gelfland EW, Kappler J, Marrack P, Kotzin BL. Selective expansion of T cells expressing Vβ2 in toxic shock syndrome. J Exp Med. 172:1990;981-984.
33. Abe J, Kotzin BL, Jujo K, Melish ME, Glode MP, Kohsaka T, Leung DY. Selective expansion of T cells expressing T cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease. Proc Natl Acad Sci USA. 89:1992;4066-4070.
34. Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science. 248:1990;705-711.
35. Paliard X, West SG, Lafferty JA, Clements JR, Kappler JW, Marrack P, Kotzin BL. Evidence for the effects of a super-antigen in rheumatoid arthritis. Science. 253:1991;325-329.
36. Grunewald J, Wigzell H. T cell expansions in healthy individuals. Immunologist. 1996;. in press.
37. Posnett D, Sinha R, Kabak S, Russo C. Clonal populations of T cells in normal elderly humans: the T cell equivalent to "Benign Monoclonal Gammapathy" J Exp Med. 179:1994;609-618.
38. Farrant JM, Hayllar KM, Wilkinson ML, Karani J, Portamann BC, Westaby D, Williams R. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology. 100:1991;1710-1717.
39. Dickson ER, Murtaugh PA, Wiesner RH, Grambsch PM, fleming TR, Ludwig J, La Russo NF, Malinchol M, Chapman RW, Kaplan MM. Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology. 103:1992;1893-1901.
40. Diu A, Romange F, Genevee C, Rocher C, Bruneau J-M, David A, Praz F, Hercend T. Fine specificity of monoclonal antibodies directed at human T cell receptor variable regions; comparison with oligonucleotide-driven amplification for evaluation of Vβ expression. Eur J Immunol. 23:1993;1422-1429.
41. Hayashi Y, Hanaeji N, Hamano H. Pathogenesis of Sjögren's syndrome-like autoimmune lesions in MRL/lpr mice. Pathol Int. 44:1994;559-568.
42. Tsianos EV, Hoofnagle JH, Fox PC, Alspaugh M, Jones EA, Schafer DF, Moutsopoulos HM. Sjögren's syndrom in patients with biliary cirrhosis. Hepatology. 11:1990;730-734.
43. Posnett DN, Schmelkin I, Burton DA, August A, MacGrath H, Mayer LF. T cell antigen receptor V gene usage increases in Vβ8+ T cells in Crohn's disease. J Clin invest. 85:1990;1770-1776.
44. Shalon L, Gulwani-Akolkar B, Stanely EF, Akolkar PP, Panja A, Mayer L, Silver J. Evidence of altered T-cell receptor repertoire in Crohn's disease. Autoimmunity. 17:1994;301-307.
45. Spencer J, Choy MY, MacDonald. T cell receptor Vβ expression by mucosal T cells. J Clin Pathol. 44:1991;915-918.
46. Acha-Oreba H, Mitchell DJ, Timmermann L, Wrait D, Tausch G, Waldor M, Zamvil S, McDevitt H, Steinman L. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell. 54:1988;263-273.
47. Grunewald J, Janson CH, Wigzell H. Biased expression of individual T cell receptor V gene segments in CD4+ and CD8+ human peripheral blood lymphocytes. Eur J Immunol. 21:1991;819-822.